Intrinsic resistance to the MEK1/2 inhibitor AZD6244 (ARRY-142886) is associated with weak ERKI/2 signalling and/or strong P13K signalling in colorectal cancer cell linesINTERNATIONAL JOURNAL OF CANCERIF4.72009-09-18135PREAI
Colorectal cancer cells with the BRAFV600E mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIMONCOGENEIF7.32008-09-2270OAAI
Inhibition of COX-2 with NS-398 decreases colon cancer cell motility through blocking epidermal growth factor receptor transactivation: possibilities for combination therapyNS-398抑制COX-2通过阻断表皮生长因子受体反式激活降低结肠癌细胞运动性: 联合治疗的可能性CELL PROLIFERATIONIF5.62007-09-1443OAAI
Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer (vol 1766, pg 104, 2006)BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCERIF8.32007-06-010PREAI
Prostaglandin F2α stimulates motility and invasion in colorectal tumor cellsINTERNATIONAL JOURNAL OF CANCERIF4.72007-04-1669OAAI
Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancerBIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCERIF8.32006-08-01148PREAI
Prospects in NSAID-derived chemoprevention of colorectal cancerBIOCHEMICAL SOCIETY TRANSACTIONSIF4.32005-08-0119PREAI